PER 0.00% 7.8¢ percheron therapeutics limited

Ann: Shareholder Newsletter, page-96

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 13,710 Posts.
    lightbulb Created with Sketch. 1460
    “How much does a Phase 2 molecule cost? • A Phase 2 molecule is worth $249M and it costs $74M to get to Phase 2.
    A Phase 3 molecule is worth $1.1B and it costs $154M to get to that point. Unless you can generate high-quality hits or leads very quickly and cheaply, you're better off taking drugs to the clinic yourselves rather than partnering too early.”


    As mention d earlier many times
    Anp is grossly undervalued $$

    and if there is a takeover offer
    Expect north of $1.50
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
7.8¢
Change
0.000(0.00%)
Mkt cap ! $80.86M
Open High Low Value Volume
7.9¢ 7.9¢ 7.7¢ $180.5K 2.302M

Buyers (Bids)

No. Vol. Price($)
4 589756 7.8¢
 

Sellers (Offers)

Price($) Vol. No.
7.9¢ 1050000 3
View Market Depth
Last trade - 16.10pm 05/11/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.